Semiconductor design leader Synopsys delivered a severe blow to its investors this week. The company’s stock collapsed by more than 35% after it released quarterly earnings accompanied by a drastically reduced outlook. Initial appearances of a standard quarterly update quickly gave way to an alarming revelation with potential ramifications across the entire sector.
Financial Performance and Revised Guidance
For the third quarter of its 2025 fiscal year, Synopsys reported revenue of $1.74 billion. Its net income landed at $242.5 million, equating to $1.50 per share. This represents a stark decline compared to the $2.73 per share earned during the same period last year.
The core of the market’s negative reaction stems from a surprisingly weak fourth-quarter forecast. Management now anticipates earnings per share will fall between $2.76 and $2.80, a figure substantially below consensus analyst estimates. This downward revision signals that the challenges experienced in Q3 are expected to persist.
Should investors sell immediately? Or is it worth buying Synopsys?
Furthermore, the company’s full-year outlook was also downgraded. This has forced the market to price in a period of weaker profitability, marking a complete reversal from previous expectations. Financial analysts are now compelled to undertake fundamental revisions to their valuation models.
Underlying Causes of the Weakness
The disappointing results and guidance are rooted in significant issues within the Design-IP division. Company executives identified three primary contributing factors:
- Major Client Setback: Synopsys is grappling with substantial difficulties involving a major foundry customer, widely believed to be Intel. This critical business relationship appears to be severely compromised.
- Impact of Export Controls: New international trade restrictions have disrupted design-start projects and exacerbated the company’s pre-existing weakness in the Chinese market.
- Internal Strategic Missteps: Management conceded that certain internal decisions regarding product roadmaps and resource allocation failed to deliver the intended outcomes.
In a related development, a law firm has already initiated an investigation into whether Synopsys may have misled investors concerning its customer-related risks. The company’s recent acquisition of Ansys, finalized in July, was noted as having no material impact on the current quarterly figures.
Ad
Synopsys Stock: Buy or Sell?! New Synopsys Analysis from October 1 delivers the answer:
The latest Synopsys figures speak for themselves: Urgent action needed for Synopsys investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 1.
Synopsys: Buy or sell? Read more here...